Foreign investors are hitting the eject button on India. As of mid-2026, we’ve seen over $24 billion in net outflows from the country’s public markets. Yet, Singapore’s state-owned investor Temasek is moving in the opposite direction. While the rest of the world gets skittish, Temasek’s recent bets are paying off in a massive way.
The strategy isn't complicated. They aren't chasing the hype; they’re buying into the structural reality of a country that isn't slowing down.
The IPO surge that proves the thesis
You don't need a PhD in finance to see the results. Three major Indian portfolio companies—Shiprocket, Milky Mist, and Molbio Diagnostics—have recently hit the public markets. The numbers are hard to ignore. Shiprocket debuted with a 35% premium, eventually climbing nearly 50% above its IPO price. Milky Mist followed up with a 40% jump on its first day.
These aren't random wins. They reflect a deliberate focus on companies that actually solve problems for India’s massive, shifting domestic market.
Consider why this matters. Most institutional investors treat emerging markets like a speculative trade. They jump in when growth looks easy and run away the moment the Fed hikes rates or currency volatility spikes. Temasek is doing the opposite. By holding significant stakes—often over 5%—in these firms long before they go public, they capture the growth that happens in the private phase and keep the upside through the IPO.
Why India is different right now
The "India Story" has been told a thousand times, usually by people trying to sell you a mutual fund. But look at the actual data. Temasek has funneled nearly $9 billion into India over the last three years. That’s a loud statement.
Why are they doing it when everyone else is selling?
- Domestic Consumption: India is no longer just about exporting IT services. It’s about 1.4 billion people buying dairy, logistics services, and healthcare.
- Infrastructure Readiness: You can’t build a digital economy without logistics. That’s why Shiprocket is a core play. It isn't just a "tech" company; it’s the backbone of India’s e-commerce logistics.
- Healthcare Professionalization: Look at the success of Manipal Health and Molbio. As the middle class grows, the demand for standardized, reliable healthcare is going vertical.
The risk that nobody mentions
It’s easy to look at a 40% pop on a stock and call it a genius move. But Temasek faces the same risks as any other foreign investor. Currency depreciation is real. When the Singapore dollar strengthens against the Indian rupee, as it has by over 13% this past year, those returns get hammered on paper.
They mitigate this through a mix of hedging and long-term positioning. They aren't looking at next quarter’s earnings. They’re looking at the next decade. If you’re a retail investor trying to mimic this, you’ll get burned because you lack the capital to wait out a five-year downcycle.
How to actually think about these markets
If you’re watching Temasek’s moves, don't just look for "the next Indian IPO." That’s a losing game. The real takeaway is simpler.
First, stop looking for "growth at any price." Temasek’s success comes from backing companies that are already integrated into the daily life of their home market. Whether it’s logistics or dairy, these companies produce value regardless of whether the stock market is having a "good" or "bad" day.
Second, understand that institutional dominance in these sectors is growing. When a state-backed giant like Temasek takes a 50% stake in a massive health provider like Manipal, it signals a shift toward institutional-grade infrastructure. The days of "easy" early-stage venture capital in India are fading. The future is in scaled, established, and increasingly public businesses.
Don't panic because foreign flows are negative. Sometimes, the best time to enter is when the rest of the world is too scared to stay. Keep your eyes on the companies providing the essential services, not the ones selling the latest buzzword.
Build your portfolio based on long-term structural demand. Let the day traders worry about the volatility. You’ve got a bigger timeline to worry about.
